Israeli startup Sweetch leverages AI for diabetes prevention

Numerous medical stakeholders — from providers to startups — are targeting diabetes management as a way to improve patients’ health and cut down on overall healthcare costs. But one company out of Israel wants to stay one step ahead by focusing on preventing diabetes altogether.

Founded in 2013, Sweetch offers an artificial intelligence-based platform that seeks to identify those at high risk of developing type 2 diabetes.